Our Pricing

Bio-Oil

Published on: June 03, 2026

Many patients searching for bio oil weight loss UK pharmacy solutions are managing skin changes during their weight management journey. At Cured Pharmacy, we offer comprehensive weight loss treatments alongside guidance on supporting your skin throughout the process, with transparent pricing and expert clinical support from our UK-registered team.

Understanding Skin Changes During Weight Loss

Significant weight reduction can lead to visible skin changes, including stretch marks, loose skin, and changes in skin elasticity. When patients lose substantial amounts of body weight — particularly the 15-22.5% reductions seen in modern weight loss medication trials — the skin may not immediately adapt to the new body contours [1].

Clinical studies of GLP-1 receptor agonists show that gradual, sustained weight loss produces better outcomes for both metabolic health and skin adaptation compared to rapid weight reduction [1]. Supporting your skin throughout this journey with appropriate skincare products and maintaining adequate hydration can help optimise results.

The rate of weight loss matters significantly. Patients using tirzepatide in the SURPASS trials experienced average weight reductions of 20-22.5% over 72 weeks, allowing skin time to adapt gradually [2]. This controlled approach, combined with proper skin care, may help minimise the appearance of loose skin compared to more rapid weight loss methods.

How Modern Weight Loss Treatments Work

Today's prescription weight loss medications work through sophisticated hormonal pathways that regulate appetite, blood sugar, and metabolism. GLP-1 receptor agonists like semaglutide and liraglutide mimic natural gut hormones that signal fullness to the brain, whilst dual-action treatments like tirzepatide activate both GIP and GLP-1 receptors for enhanced efficacy [1][2].

These medications are licensed by the MHRA for weight management in adults with a BMI of 30 or above, or 27 or above with weight-related health conditions. All require prescription from a UK-registered prescriber following clinical assessment [3].

Unlike older weight loss tablets that simply block fat absorption, modern injectable treatments address the underlying hormonal signals that regulate appetite and metabolism. Clinical trials demonstrate average weight reductions of 15-22.5% when combined with lifestyle modifications, significantly higher than diet and exercise alone [2][4].

Injectable vs Oral Weight Loss Medications

Injectable GLP-1 treatments like Mounjaro, Wegovy, and Saxenda work systemically through hormone receptor activation, whilst oral medications like Orlistat function locally in the digestive system by blocking fat absorption. Injectable options typically produce greater weight reductions but require weekly or daily injections, whereas oral treatments are taken with meals but may cause digestive side effects if dietary fat intake is too high [3][4].

Mounjaro: The Most Effective Licensed Treatment

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK for weight management. This dual mechanism produces superior weight loss outcomes compared to single-pathway treatments, with clinical trial participants achieving average reductions of 22.5% body weight over 72 weeks on the highest dose [2].

At Cured Pharmacy, Mounjaro is available from £135.00 following a free online consultation with our UK prescribers. The treatment requires once-weekly subcutaneous injection using a pre-filled KwikPen device, with doses gradually increased over several months to optimise tolerance and efficacy.

The SURPASS clinical trial programme demonstrated that tirzepatide not only produces significant weight reduction but also improves cardiovascular risk markers, blood pressure, and glycaemic control in patients with or without type 2 diabetes [2]. All prescription treatments are subject to clinical assessment and prescriber approval based on your individual medical history.

Who Can Use Mounjaro for Weight Loss

Mounjaro is licensed for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, dyslipidaemia, or obstructive sleep apnoea. Your UK prescriber will assess your suitability during the online consultation, considering your medical history, current medications, and weight management goals [3].

Wegovy and Saxenda: Proven GLP-1 Alternatives

Wegovy contains semaglutide, a GLP-1 receptor agonist administered once weekly via subcutaneous injection. In the STEP clinical trials, participants achieved average weight reductions of 15% over 68 weeks when combined with lifestyle interventions [4]. At Cured Pharmacy, Wegovy starts from 10% offering an effective alternative for patients who may not require the dual-action mechanism of tirzepatide.

Saxenda contains liraglutide, a daily injectable GLP-1 treatment that has been licensed in the UK since 2015. Whilst requiring daily rather than weekly administration, Saxenda provides a well-established option with extensive real-world safety data. Clinical trials demonstrated average weight loss of 8-9% over 56 weeks, with Saxenda available from £135.00 at Cured Pharmacy [4].

Both medications work by activating GLP-1 receptors in the brain that regulate appetite and food intake. Common side effects include nausea, vomiting, and diarrhoea, typically most pronounced during dose escalation phases. These effects usually diminish over time as the body adapts to treatment [3][4].

Oral Weight Loss Medications: Orlistat and Mysimba

Orlistat works by inhibiting pancreatic lipase enzymes, preventing approximately 30% of dietary fat from being absorbed in the digestive system. Available as prescription-strength 120mg capsules or lower-dose variants, Orlistat is taken three times daily with meals containing fat. At Cured Pharmacy, generic Orlistat starts from £135.00 with branded Xenical available from £135.00.

Mysimba combines naltrexone and bupropion to reduce appetite and food cravings through central nervous system pathways. Clinical trials showed average weight reductions of 5-10% over 56 weeks when combined with lifestyle modifications [5]. Mysimba requires gradual dose escalation over four weeks and is available from £135.00 at Cured Pharmacy.

Oral medications suit patients who prefer not to use injections or who have contraindications to GLP-1 treatments. However, injectable options typically produce greater weight reductions in clinical trials. Your UK prescriber will recommend the most appropriate treatment based on your medical history, preferences, and weight management goals [3][5].

Managing Side Effects with Oral Treatments

Orlistat may cause gastrointestinal side effects including oily stools, increased bowel movements, and flatulence, particularly when dietary fat intake exceeds recommended levels. These effects can be minimised by following a reduced-fat diet with no more than 30% of calories from fat. Mysimba may cause nausea, constipation, and headache, typically improving after the initial titration period [5].

Supporting Your Skin During Bio Oil Weight Loss UK Pharmacy Journey

Maintaining skin health during significant weight reduction involves multiple factors beyond topical skincare products. Adequate protein intake supports collagen synthesis, whilst hydration helps maintain skin elasticity. Gradual weight loss — as achieved with prescription medications under medical supervision — allows skin time to adapt to changing body contours [1].

Many patients use skincare products to support skin appearance during weight loss. Whilst no topical product can prevent loose skin following major weight reduction, maintaining a comprehensive skincare routine alongside medical weight management may help optimise skin condition. Our clinical team can provide guidance on managing skin changes as part of your overall treatment plan.

At Cured Pharmacy, we focus on evidence-based medical weight loss treatments that produce sustainable results. All prescription medications require assessment by our UK-registered prescribers, with ongoing support throughout your treatment journey. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all clinical services to ensure the highest standards of pharmaceutical care.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Dahl, D., et al. (2022). Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial. JAMA, 327(6), 534–545. https://doi.org/10.1001/jama.2022.0078 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Public Assessment Report: Mounjaro 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg solution for injection in pre-filled pen. GOV.UK. [accessed 13 August 2026]
4. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. Greenway, F. L., et al. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 376(9741), 595–605. https://doi.org/10.1016/S0140-6736(10)60888-4 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.